Cargando…
Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review
BACKGROUND: Health systems are often susceptible to corruption risks. Corruption within health systems has been found to negatively affect the efficacy, safety, and, significantly, equitable distribution of health products. Enforcing effective anti-corruption mechanisms is important to reduce the ri...
Autores principales: | Griffore, Kari A., Bowra, Andrea, Guilcher, Sara J.T., Kohler, Jillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675881/ https://www.ncbi.nlm.nih.gov/pubmed/38001483 http://dx.doi.org/10.1186/s12992-023-00994-x |
Ejemplares similares
-
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
por: Kohler, Jillian Clare, et al.
Publicado: (2020) -
Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations
por: Gorodensky, Ariel, et al.
Publicado: (2022) -
The Global Fund: why anti-corruption, transparency and accountability matter
por: Chang, Zhihao, et al.
Publicado: (2021) -
An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement
por: Mackey, Tim K., et al.
Publicado: (2020) -
An exploration of anti-corruption and health in international organizations
por: Bowra, Andrea, et al.
Publicado: (2022)